Stock Market & Financial Investment News

News Breaks December 21, 2012 17:14 EDT ALXA Alexza's Adasuve FDA approval has several post approval requirements Alexza has several post-approval requirements, including a large observational clinical trial designed to gather patient safety data based on the real-world use of Adasuve, as well as a clinical program addressing the safety and efficacy of Adasuve in agitated adolescent patients. News For ALXA From The Last 14 Days Check below for free stories on ALXA the last two weeks. Sign up for a free trial to see the rest of the stories you've been missing. May 22, 2013 16:23 EDT ALXA Alexza Pharmaceuticals chief commercial officer to leave company Subscribe for More Information May 14, 2013 16:13 EDT ALXA Alexza Pharmaceuticals reports Q1 EPS ($1.31), consensus (45c) Subscribe for More Information Sign up for a free trial to see the rest of the stories you've been missing.